Education Efforts to Help Increase Biosimilar Understanding and Acceptance
Sarah Ikenberry, M.A., explains the FDA’s comprehensive efforts to enhance the understanding and acceptance of biosimilars among healthcare providers and the public. These educational initiatives clarify the benefits, safety, and efficacy of biosimilars, promoting their broader adoption in the U.S. healthcare system.
